(Q53301048)

13 May 2018

title

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. (English)

1 reference

13 May 2018

1 reference

K Ishiyama

1

1 reference

13 May 2018

T Katagiri

2

1 reference

13 May 2018

T Hoshino

3

1 reference

13 May 2018

T Yoshida

4

1 reference

13 May 2018

M Yamaguchi

5

1 reference

13 May 2018

S Nakao

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

13 September 2010

1 reference

13 May 2018

Bone Marrow Transplantation

published in

1 reference

13 May 2018

volume

46

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

page(s)

863-869

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2010.201

exact match

0 references

cites work

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Human herpesvirus-6 in transplantation: an emerging pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Impact of human herpesvirus-6 after haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Analysis of immune reconstitution in children undergoing cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Monitoring four herpesviruses in unrelated cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.201

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.201

1 reference

13 May 2018

1 reference

13 May 2018